Clinical Trials

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

70 enrolled

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04659343 2026-05-04

TDM for Optimized Outcome in Patients With mRCC.

Genitourinary

Kidney Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05838638 2026-05-01

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

610 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07354971 2026-04-28

IMMUNO-FIT Observational Study

67 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00093353 2026-04-14

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1 Completed

30 enrolled

CNS

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions

NCT07524829 2026-04-13

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

124 enrolled

Treatment Adherence and Compliance, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05096338 2026-03-23

PCT

Active not recruiting

Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT07238075 2026-02-17

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

290 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Phase 3 Completed

800 enrolled 22 charts

Phase 2 Active not recruiting

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

42 enrolled

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05512169 2026-01-15

MPGx-INDALL

556 enrolled

Neoplasms, Genetic Predisposition to Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07319364 2026-01-06

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

90 enrolled

Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06120712 2025-12-23

MIZAR-002

Phase 1/2 Completed

18 enrolled

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05417750 2025-12-10

MIZAR-001

Phase 1 Completed

43 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT07264985 2025-12-04

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Not yet recruiting

60 enrolled

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT07237906 2025-11-20

Neutropenia With TNF-α Inhibitors

122 enrolled

Arthritis, Neutropenia, Drug-Related Side Effects and Adverse Reactions

NCT05078190 2025-11-06

CCT2

Active not recruiting

Breast Neoplasms, Cardiovascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT06726590 2025-09-12

IPGx Registry

3,000 enrolled

Diabetes Mellitus, Heart Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive, Drug-Related Side Effects and Adverse Reactions

NCT07063706 2025-07-18

Pharmaceutical Care for Patients Using Capecitabine

Phase NA Completed

176 enrolled

Colonic Neoplasms, Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06789601 2025-06-19

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Phase 1/2 Recruiting

100 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06716619 2025-03-26

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

32 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT03711110 2025-03-21

CARTIER

BreastGastrointestinalLymphoidPlasma cell

514 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

80 enrolled

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05355168 2024-12-31

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Phase 2 Completed

35 enrolled

Esophageal Squamous Cell Carcinoma, Drug-Related Side Effects and Adverse Reactions

NCT06302062 2024-12-03

TAL-T

Phase 3 Not yet recruiting

23 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

399 enrolled

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

NCT06558084 2024-08-16

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

64 enrolled

Breast Neoplasms, Disease Progression, Drug-Related Side Effects and Adverse Reactions

NCT04696081 2024-08-09

AFIB-CANCER

1,000 enrolled

Atrial Fibrillation, Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06483685 2024-07-03

RADIANTS

500,000 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04824352 2024-05-14

AIEO

Phase 2 Suspended

44 enrolled

Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT05022797 2024-05-13

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Phase 2 Terminated

3 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Drug-Related Side Effects and Adverse Reactions

NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

GenitourinaryOther hematologic neoplasmSarcoma

1,000 enrolled

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

NCT06291688 2024-03-04

Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability

Phase NA Unknown

110 enrolled

Neoplasms, Neoplasms, Second Primary, Drug-Related Side Effects and Adverse Reactions

NCT05717699 2024-02-28

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

18 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Drug-Related Side Effects and Adverse Reactions

NCT05717712 2024-02-28

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

18 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Drug-Related Side Effects and Adverse Reactions

NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

2,000 enrolled

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

34 enrolled

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05137847 2023-12-12

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

118 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Drug-Related Side Effects and Adverse Reactions

NCT06152471 2023-11-30

ASF-BC

Phase 3 Unknown

100 enrolled

CNSClassical hematologyLymphoid

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Phase 2 Terminated

17 enrolled 7 charts

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Phase 1 Terminated

8 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT03882580 2023-04-24

NEOCARDIO

5,000 enrolled

Heart Diseases, Heart Failure, Metabolic Diseases, Vascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT04279470 2023-04-13

CARTABLE

100,000 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05800054 2023-04-05

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

210 enrolled

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

30 enrolled

Sarcoma

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04770922 2023-02-16

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

80 enrolled